HALCINONIDE

SynDRA canonical compound SYN0023231 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	NR3C1
Mechanism of action	Glucocorticoid receptor agonist
Indication	corticosteroid-responsive dermatoses
Disease area	dermatology

All known targets

alcinonide
halciderm
halcimat
halog
Halcinonida
NSC-758413
SO-18566
SQ-18566
Halog
Halog-e
Halciderm
Halcimat
SI86V6QNEG
Halcort
NSC 758413
SO 18566
(1S,2S,4R,8S,9S,11S,12R,13S)-8-(2-chloroacetyl)-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-17-en-16-one
(1S,2S,4R,8S,9S,11S,12R,13S)-8-(2-chloroacetyl)-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icos-17-en-16-one
(4R,8S)-8-(2-Chloroacetyl)-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icos-17-en-16-one
21-Chloro-9-fluoro-11beta,16alpha,17-trihydroxypregn-4-ene-3,20-dione cyclic 16,17-acetal with acetone
SQ-18,566
Betacorton
Halcinonidum
HALOG-E
Ascochrom
Volog
UNII-SI86V6QNEG
Halcinonidum [INN-Latin]
Halcinonida [INN-Spanish]
NCGC00016621-01
(11?,16?)-21-Chloro-9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregn-4-ene-3,20-dione
CAS-3093-35-4
EINECS 221-439-6
Prestwick_1069
Halog (TN)
BRN 1358242
Halcinonide [USAN:USP:INN:BAN:JAN]
HALCINONIDE [MI]